Clinical Trial Update: Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost [Phase 4]

View source ↗

Summary

Phase 4 trial comparing efficacy and ocular surface outcomes between Monoprost and BAK-preserved latanoprost in glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Latanoprost (Latanoprost)
• Monoprost (unavailable)

Snippet

Sponsor: CHA University | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED